The 20 Best Thrombocytopenia Doctors Near Me in Parkville, MD

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Dr. Gloria F. Gerber is an Assistant Professor of Medicine at Johns Hopkins University in the Division of Hematology. She received her undergraduate degree in Biology with High. Dr. Gerber is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Hemolysis, and Hemolytic Anemia. Dr. Gerber is board certified in American Board Of Internal Medicine.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, and Congenital Hemolytic Anemia. Dr. Naik is board certified in American Board Of Internal Medicine.

Charles Padgett is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Padgett is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer.

Mahsa Mohebtash is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Mohebtash is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Huzefa Bahrain is a Hematologist practicing medicine in Rosedale, Maryland. Dr. Bahrain is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Neuroblastoma, and Hereditary Neuroblastoma.

Syed Nasir is an Oncologist practicing medicine in Towson, Maryland. Dr. Nasir is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is currently accepting new patients.

Ravi Anandakrishnan is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Anandakrishnan is rated as an Advanced provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Lung Cancer, Pleuropulmonary Blastoma, and Thrombocytopenia.

Gang Chen is a Hematologist practicing medicine in Towson, Maryland. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Colorectal Cancer, Familial Colorectal Cancer, and Paget Disease of the Breast.

Dr. Michael Cole is a distinguished graduate of the US Air Force Academy (2006), and as an Alberta Bart Holaday Scholar went on to complete his Doctor of Philosophy in Biochemistry (2010) at University of Oxford under the direction of Prof Paul Wentworth Jr. and Prof Bob Sim. He focused his research on peptide chemistry and acyl group reactivity in thioester-containing proteins such as complement proteins, C3 and C4. He fulfilled his Air Force commitment as a chemist and Assistant Professor of Chemistry at the US Air Force Academy. He came to Johns Hopkins University for medical school in 2014. Since that time, he has stayed at Johns Hopkins completing his medical degree (2018), internal medicine residency training (2021), and hematology fellowship (2024). In 2024, he joined the Division of Hematology as an Instructor. Dr. Cole is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses D-Minus Hemolytic Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, and Atypical Hemolytic Uremic Syndrome (aHUS). Dr. Cole is board certified in American Board Of Internal Medicine.

Dr. Moonjung Jung is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Jung graduated Summa Cum Laude from Ewha Womans University College of Medicine in Seoul, South Korea. She then completed the Internal Medicine residency training at Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX and the Hematology and Medical Oncology fellowship training at National Institutes of Health, Bethesda, MD. In 2016, Dr. Jung joined the Rockefeller University as an Instructor in Clinical investigation. She received M.S. in Clinical Investigation from the Rockefeller University. In 2021, Dr. Jung joined the Johns Hopkins University School of Medicine as faculty in the Division of Hematology. Dr. Jung is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Fanconi Anemia, Congenital Aplastic Anemia, Aplastic Anemia, and Anemia. Dr. Jung is board certified in American Board Of Internal Medicine.

Michael Streiff is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Streiff is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Dr. Katherine Rappazzo is a clinical associate in the division of hematology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hematologic disorders such as anemia, iron deficiency, hereditary hemorrhagic telangiectasia, myeloproliferative disorders, venous thromboembolism, bleeding disorders, hypercoagulable states, thrombocytopenia, leukopenia, and disorders of iron metabolism. Dr. Rappazzo is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Hodgkin Lymphoma, and Tissue Biopsy. Dr. Rappazzo is board certified in American Board Of Internal Medicine.

Panayotis Ledakis is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Ledakis is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. He is also highly rated in 79 other conditions, according to our data. His clinical expertise encompasses Appendix Cancer, Desmoplastic Small Round Cell Tumor, Anemia, Colorectal Cancer, and Ureteroscopy.

Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine.

Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Brahmer is board certified in American Board Of Internal Medicine.

Dr. Kristen Marrone is a thoracic medical oncology specialist in Baltimore, caring for patients with lung cancer and esophageal cancer. She is the Program Director of the Hematology/Medical Oncology Fellowship Program at the Johns Hopkins School of Medicine. Dr. Marrone received her undergraduate degree in psychology with a neuroscience concentration from Pennsylvania State University. She earned her M.D. from Drexel University College of Medicine. She completed her residency at Yale-New Haven Hospital and performed a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. Marrone joined the Johns Hopkins faculty in 2017. Her research interests include clinical trial development and translational studies focusing on optimization of immunotherapy in oncogene driven non-small cell lung cancer. Dr. Marrone is a member of the American Association of Cancer Research, the American Society of Clinical Oncology, the International Association for Study of Lung Cancer and the Society for Immunotherapy in Cancer. Dr. Marrone is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Marrone is board certified in American Board Of Internal Medicine.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Dezern is board certified in American Board Of Internal Medicine.